News | November 04, 2007

Biomist Inc. Develops New Technology to Kill Superbug MRSA

November 5, 2007 - The recent surge in Methicillin-resistant Staphylococcus aureus (MRSA) cases have thrust the infection into the spotlight and some hospitals are turning to a new technology from Biomist Inc. that converts alcohol into a nonflammable vapor, making it possible to sanitize surfaces that cannot be quickly sanitized by other methods.

The new system, known as NAV-CO2, uses liquid carbon dioxide as a propellant to spray a fine alcohol mist. Using this process, oxygen is temporarily displaced by an envelope of rapidly expanding CO2 gas, rendering the vapor nonflammable.

“Veterans Administration hospitals are leading the way in U.S. MRSA prevention,” said Charles Carman, a management consultant working with hospitals on infection prevention. “The difference is the leadership. VA Hospitals have made combating MRSA a priority, and have made investments in NAV-CO2 systems. Ultimately, VA Hospitals will recover the investment many times over in labor savings and achieve a hygienic environment for patients, visitors and staff.”

For more information: